Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Nature Communications
|
March 12, 2024
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial
David Hsiehchen, Muhammad S Beg, Radhika Kainthla, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Differences in systemic immune parameters in individuals with lung cancer according to race
Mitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.
JTO Clinical and Research Reports
|
December 2, 2024
Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer
Mitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.
Lancet (London, England)
|
October 23, 2023
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Shukui Qin, Minshan Chen, Ann-Lii Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2025
Characterization of plasma cell-free DNA variants as of tumor- or clonal hematopoiesis-origin in 16,812 advanced cancer patients
Daniel Magee, Valeriy Domenyuk, Jim Abraham, et al.
Journal for Immunotherapy of Cancer
|
September 10, 2025
Innate and adaptive immune features associated with immune-related adverse events
Shaheen Khan, Venkat S Malladi, Mitchell S von Itzstein, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Cmai: Predicting Antigen-Antibody Interactions from Massive Sequencing Data
Bing Song, Kaiwen Wang, Saiyang Na, et al.
NPJ Precision Oncology
|
July 3, 2023
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
Kai Zimmer, Florian Kocher, Gerold Untergasser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2025
Presurgical ablative radiation is associated with local control and immune response in pancreatic cancer
Peter Q Leung, Eslam A Elghonaimy, Ahmed M Elamir, et al.
Biorxiv : the Preprint Server for Biology
|
December 18, 2023
pan-MHC and cross-Species Prediction of T Cell Receptor-Antigen Binding
Yi Han, Yuqiu Yang, Yanhua Tian, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Nature Communications
|
March 12, 2024
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial
David Hsiehchen, Muhammad S Beg, Radhika Kainthla, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Differences in systemic immune parameters in individuals with lung cancer according to race
Mitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.
JTO Clinical and Research Reports
|
December 2, 2024
Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer
Mitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.
Lancet (London, England)
|
October 23, 2023
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
Shukui Qin, Minshan Chen, Ann-Lii Cheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 11, 2025
Characterization of plasma cell-free DNA variants as of tumor- or clonal hematopoiesis-origin in 16,812 advanced cancer patients
Daniel Magee, Valeriy Domenyuk, Jim Abraham, et al.
Journal for Immunotherapy of Cancer
|
September 10, 2025
Innate and adaptive immune features associated with immune-related adverse events
Shaheen Khan, Venkat S Malladi, Mitchell S von Itzstein, et al.
Biorxiv : the Preprint Server for Biology
|
July 15, 2024
Cmai: Predicting Antigen-Antibody Interactions from Massive Sequencing Data
Bing Song, Kaiwen Wang, Saiyang Na, et al.
NPJ Precision Oncology
|
July 3, 2023
PBRM1 mutations might render a subtype of biliary tract cancers sensitive to drugs targeting the DNA damage repair system
Kai Zimmer, Florian Kocher, Gerold Untergasser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 2025
Presurgical ablative radiation is associated with local control and immune response in pancreatic cancer
Peter Q Leung, Eslam A Elghonaimy, Ahmed M Elamir, et al.
Biorxiv : the Preprint Server for Biology
|
December 18, 2023
pan-MHC and cross-Species Prediction of T Cell Receptor-Antigen Binding
Yi Han, Yuqiu Yang, Yanhua Tian, et al.
Page
of 7